111 related articles for article (PubMed ID: 11779201)
1. Regulation of transformed state by calpastatin via PKCepsilon in NIH3T3 mouse fibroblasts.
Hiwasa T; Nakata M; Nakata M; Ohno S; Maki M; Suzuki K; Takiguchi M
Biochem Biophys Res Commun; 2002 Jan; 290(1):510-7. PubMed ID: 11779201
[TBL] [Abstract][Full Text] [Related]
2. Carbon source-dependent regulation of cell growth by murine protein kinase C epsilon expression in Saccharomyces cerevisiae.
Parissenti AM; Villeneuve D; Kirwan-Rhude A; Busch D
J Cell Physiol; 1999 Feb; 178(2):216-26. PubMed ID: 10048586
[TBL] [Abstract][Full Text] [Related]
3. Antisense inhibition of protein kinase Calpha reverses the transformed phenotype in human lung carcinoma cells.
Wang XY; Repasky E; Liu HT
Exp Cell Res; 1999 Jul; 250(1):253-63. PubMed ID: 10388539
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C-epsilon associates with the Raf-1 kinase and induces the production of growth factors that stimulate Raf-1 activity.
Ueffing M; Lovrić J; Philipp A; Mischak H; Kolch W
Oncogene; 1997 Dec; 15(24):2921-7. PubMed ID: 9416835
[TBL] [Abstract][Full Text] [Related]
5. PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase.
Cacace AM; Ueffing M; Philipp A; Han EK; Kolch W; Weinstein IB
Oncogene; 1996 Dec; 13(12):2517-26. PubMed ID: 9000126
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C isozymes in progressively transformed rat embryo fibroblasts.
Liao L; Ramsay K; Jaken S
Cell Growth Differ; 1994 Nov; 5(11):1185-94. PubMed ID: 7848920
[TBL] [Abstract][Full Text] [Related]
7. The involvement of protein kinase C isoenzymes alpha, epsilon and zeta in the sensitivity to antitumor treatment and apoptosis induction.
Spitaler M; Wiesenhofer B; Biedermann V; Seppi T; Zimmermann J; Grunicke H; Hofmann J
Anticancer Res; 1999; 19(5B):3969-76. PubMed ID: 10628339
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase Cepsilon is oncogenic in colon epithelial cells by interaction with the ras signal transduction pathway.
Perletti GP; Concari P; Brusaferri S; Marras E; Piccinini F; Tashjian AH
Oncogene; 1998 Jun; 16(25):3345-8. PubMed ID: 9681835
[TBL] [Abstract][Full Text] [Related]
9. Increase in ultraviolet sensitivity by overexpression of calpastatin in ultraviolet-resistant UVr-1 cells derived from ultraviolet-sensitive human RSa cells.
Hiwasa T; Arase Y; Kikuno K; Hasegawa R; Sugaya S; Kita K; Saido T; Yamamori H; Maki M; Suzuki N
Cell Death Differ; 2000 Jun; 7(6):531-7. PubMed ID: 10822276
[TBL] [Abstract][Full Text] [Related]
10. The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells.
Murray SS; Grisanti MS; Bentley GV; Kahn AJ; Urist MR; Murray EJ
Exp Cell Res; 1997 Jun; 233(2):297-309. PubMed ID: 9194492
[TBL] [Abstract][Full Text] [Related]
11. The catalytic domain of PKC-epsilon, in reciprocal PKC-delta and -epsilon chimeras, is responsible for conferring tumorgenicity to NIH3T3 cells, whereas both regulatory and catalytic domains of PKC-epsilon contribute to in vitro transformation.
Wang QJ; Acs P; Goodnight J; Blumberg PM; Mischak H; Mushinski JF
Oncogene; 1998 Jan; 16(1):53-60. PubMed ID: 9467942
[TBL] [Abstract][Full Text] [Related]
12. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
14. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway.
Lo LW; Cheng JJ; Chiu JJ; Wung BS; Liu YC; Wang DL
J Cell Physiol; 2001 Sep; 188(3):304-12. PubMed ID: 11473356
[TBL] [Abstract][Full Text] [Related]
15. Role of the calpain-calpastatin system in the density-dependent growth arrest.
Stifanese R; Averna M; De Tullio R; Salamino F; Cantoni C; Mingari MC; Prato C; Pontremoli S; Melloni E
Arch Biochem Biophys; 2008 Nov; 479(2):145-52. PubMed ID: 18809371
[TBL] [Abstract][Full Text] [Related]
16. Malolactomycin D, a potent inhibitor of transcription controlled by the Ras responsive element, inhibits Ras-mediated transformation activity with suppression of MMP-1 and MMP-9 in NIH3T3 cells.
Futamura M; Kamiya S; Tsukamoto M; Hirano A; Monden Y; Arakawa H; Nishimura S
Oncogene; 2001 Oct; 20(46):6724-30. PubMed ID: 11709707
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells.
Perletti GP; Folini M; Lin HC; Mischak H; Piccinini F; Tashjian AH
Oncogene; 1996 Feb; 12(4):847-54. PubMed ID: 8632907
[TBL] [Abstract][Full Text] [Related]
18. Partial down-regulation of protein kinase C in C3H 10T 1/2 mouse fibroblasts transfected with the human Ha-ras oncogene.
Weyman CM; Taparowsky EJ; Wolfson M; Ashendel CL
Cancer Res; 1988 Nov; 48(22):6535-41. PubMed ID: 3052806
[TBL] [Abstract][Full Text] [Related]
19. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
20. Calpastatin overexpression attenuates amyloid-beta-peptide toxicity in differentiated PC12 cells.
Vaisid T; Barnoy S; Kosower NS
Neuroscience; 2008 Oct; 156(4):921-31. PubMed ID: 18786620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
